BioNTech CEO Confirms “Encouraging” Study: COVID Vaccine Could Be Approved for Older Children By Summer

If all goes well, the BioNTech-Pfizer vaccine for COVID-19 could be approved for ages 12 and older by June, and for kids above the age of six months by the fall. But the development would raise new moral and practical questions.